Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Cholangiocarcinoma × Doxorubicin × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 8 Lymphoma 3 Cardiotoxicity 2 Carcinoma, Hepatocellular 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Pseudomyxoma Peritonei 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurotoxicity Syndromes 1 Neoplasm, Residual 1 Mesothelioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Fatigue 1 Fallopian Tube Neoplasms 1 Desmoid Tumors 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Breast Cancer Organoids 1 Appendiceal Neoplasms 1

Interventions

lenvatinib 3 Surgical Procedures, Operative 3 Cholangiopancreatography, Endoscopic Retrograde 3 Blood Specimen Collection 3 Oxaliplatin 2 Liquid Biopsy 2 Immunohistochemistry 2 Immune Checkpoint Inhibitors 2 Hepatectomy 2 Base Sequence 2 pembrolizumab 1 gemcitabine-oxaliplatin regimen 1 envafolimab 1 Vascular Endothelial Growth Factor A 1 Urination 1 Tegafur 1 S 1 (combination) 1 Radiotherapy 1 Polymerase Chain Reaction 1 Pancreaticoduodenectomy 1 Palliative Care 1 Observation 1 Neoadjuvant Therapy 1 Microbiota 1 Methylation 1 Matrix Metalloproteinases 1 Mass Spectrometry 1 Liver Transplantation 1 Leucovorin 1 Interviews as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01920503 2019-02-27

CHOLANGIO

International Group of Endovascular Oncology

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡